- Home
- PRFX vs SPRC Comparison
PRFX vs SPRC Comparison
Compare PRFX & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRFX
- SPRC
- Stock Information
- Founded
- PRFX 2007
- SPRC 2004
- Country
- PRFX Israel
- SPRC Israel
- Employees
- PRFX N/A
- SPRC N/A
- Industry
- PRFX Biotechnology: Pharmaceutical Preparations
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- PRFX Health Care
- SPRC Health Care
- Exchange
- PRFX Nasdaq
- SPRC Nasdaq
- Market Cap
- PRFX 3.8M
- SPRC 3.5M
- IPO Year
- PRFX 2020
- SPRC N/A
- Fundamental
- Price
- PRFX $2.32
- SPRC $0.29
- Analyst Decision
- PRFX Hold
- SPRC
- Analyst Count
- PRFX 1
- SPRC 0
- Target Price
- PRFX N/A
- SPRC N/A
- AVG Volume (30 Days)
- PRFX 3.8M
- SPRC 161.2K
- Earning Date
- PRFX 05-14-2025
- SPRC 02-15-2025
- Dividend Yield
- PRFX N/A
- SPRC N/A
- EPS Growth
- PRFX N/A
- SPRC N/A
- EPS
- PRFX N/A
- SPRC N/A
- Revenue
- PRFX N/A
- SPRC $1,747,000.00
- Revenue This Year
- PRFX N/A
- SPRC N/A
- Revenue Next Year
- PRFX N/A
- SPRC N/A
- P/E Ratio
- PRFX N/A
- SPRC N/A
- Revenue Growth
- PRFX N/A
- SPRC N/A
- 52 Week Low
- PRFX $0.43
- SPRC $0.20
- 52 Week High
- PRFX $16.63
- SPRC $1.79
- Technical
- Relative Strength Index (RSI)
- PRFX 51.08
- SPRC 45.93
- Support Level
- PRFX $1.92
- SPRC $0.25
- Resistance Level
- PRFX $2.37
- SPRC $0.31
- Average True Range (ATR)
- PRFX 0.27
- SPRC 0.02
- MACD
- PRFX 0.07
- SPRC 0.00
- Stochastic Oscillator
- PRFX 35.36
- SPRC 78.45
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.